Nvidia will likely capture the largest percentage of the exponential compute demand. Read why I think the AI world is ...

Microsoft (MSFT) presents its latest financial quarterly results and outlook next week, and the analysts at Evercore ISI ...

While most market watchers have focused on the wildly yo-yoing stock market over the last few weeks, the Treasury bond market ...

Gilead Sciences' Q1 2025 earnings reveal challenges in oncology and Veklury sales, while HIV therapies remain strong. See why I downgraded GILD stock to Hold.

Full year revenue guidance calls for just 4.4% growth at the midpoint, with adjusted EBITDA margin expected to improve 200 ...

Tesla, Inc. Q1 results disappointed with revenue, earnings miss & pulled guidance, but an inflection point may unlock massive valuation. Click for my TSLA update.

Bristol-Myers Squibb raised its 2025 EPS outlook after a Q1 beat, with shares trading far below historical P/E levels. Find ...

Ant Group agreed to acquire a 50.55% stake in Bright Smart Securities & Commodities Group, a Hong Kong retail broker, for ...

A report from industry trade group Pharmaceutical Research and Manufacturers of America (PhRMA), conducted by Ernst & Young, ...

Expanding features up the sales cycle, along with a superior price to product value is allowing MNDY to increase the portion ...

Stay updated on lithium market trends, price shifts, EU-funded projects, U.S. critical minerals, and key developments from ...

Centerra's financial health is robust with over $1 billion in liquidity and strong free cash flow, enabling future growth ...